ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Darren R Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.